Cite
The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans.
MLA
Finlin, Brian S., et al. “The Β3-Adrenergic Receptor Agonist Mirabegron Improves Glucose Homeostasis in Obese Humans.” Journal of Clinical Investigation, vol. 130, no. 5, May 2020, pp. 2319–31. EBSCOhost, https://doi.org/10.1172/JCI134892.
APA
Finlin, B. S., Memetimin, H., Beibei Zhu, Confides, A. L., Vekaria, H. J., El Khouli, R. H., Johnson, Z. R., Westgate, P. M., Jianzhong Chen, Morris, A. J., Sullivan, P. G., Dupont-Versteegden, E. E., Kern, P. A., Zhu, B., & Chen, J. (2020). The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. Journal of Clinical Investigation, 130(5), 2319–2331. https://doi.org/10.1172/JCI134892
Chicago
Finlin, Brian S., Hasiyet Memetimin, Beibei Zhu, Amy L. Confides, Hemendra J. Vekaria, Riham H. El Khouli, Zachary R. Johnson, et al. 2020. “The Β3-Adrenergic Receptor Agonist Mirabegron Improves Glucose Homeostasis in Obese Humans.” Journal of Clinical Investigation 130 (5): 2319–31. doi:10.1172/JCI134892.